secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001193125-22-275897
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta EVP Technical Ops resigns, Bilal Arif appointed as replacement
----------------------------------------------------------------------

- William F. Ciambrone to resign as EVP Technical Operations effective Dec 31, 2022.
- Ciambrone to consult through Q2 2023 at $500/hour; equity continues vesting.
- Board appointed Bilal Arif as Chief Technical Operations Officer effective Dec 31, 2022.
- Resignation not due to any disagreement with company operations or policies.
- Ciambrone will receive 2022 annual bonus and COBRA coverage through consulting period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/d393292d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-275897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer